Let me just bring this up. The other thought is that GC for the last two years has strung us all along on Lympro in the hopes of getting to this point in history, authorizing 1 billion additional shares. He always knew he had MANF in his pocket, but needed to get to a certain point, and Elt was added this year. Both need money to get moving and into trials. Let's say Lympro results turn out to be less than stellar, buy now he has an additional billion shares to get ELt and Manf off the ground and running, regardless is we drop back to 4 or 5 cents. I can't imagine LPC signing a deal with this in mind, but they have another 24 months??? before they are off the hook and no longer have to purchase.
I for one sincerely hope this is not the case, but it bothers me that Lympro has been set in front of us as the carrot, yet we still have not made it to the promised land. And now we get three PR's starting last week to the one today, that are no more than desgined to prop up the stock price and keep folks from losing heart going into the vote for the billion shares.
GC needs substantial news before the SH meeting, otherwise the votes may not be there. He has allowed to many doubts to creep into the scenario.
Again, I hope I am wrong, but I am anxious for solid news.
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links